share_log

Applied DNA Sciences (NASDAQ:APDN) Posts Earnings Results, Beats Expectations By $0.19 EPS

Applied DNA Sciences (NASDAQ:APDN) Posts Earnings Results, Beats Expectations By $0.19 EPS

应用DNA科学公司(纳斯达克代码:APDN)公布盈利业绩,每股收益超出预期0.19美元
Financial News Live ·  2022/08/14 22:41

Applied DNA Sciences (NASDAQ:APDN – Get Rating) posted its quarterly earnings data on Thursday. The technology company reported ($0.13) earnings per share for the quarter, topping analysts' consensus estimates of ($0.32) by $0.19, Fidelity Earnings reports. Applied DNA Sciences had a negative return on equity of 148.50% and a negative net margin of 68.79%.

应用DNA科学公司(纳斯达克代码:APDN-GET Rating)周四公布了季度收益数据。富达收益报告显示,这家科技公司公布了本季度每股收益(0.13美元),比分析师普遍预期的每股收益(0.32美元)高0.19美元。应用DNA科学公司的净资产回报率为负148.50%,净利润率为负68.79%。

Applied DNA Sciences Price Performance

应用DNA科学的价格表现

APDN traded down $0.82 on Friday, reaching $3.70. 4,027,208 shares of the stock were exchanged, compared to its average volume of 20,774,652. The company's 50-day moving average price is $1.53 and its 200 day moving average price is $1.89. Applied DNA Sciences has a fifty-two week low of $0.62 and a fifty-two week high of $7.35. The firm has a market capitalization of $44.33 million, a PE ratio of -2.33 and a beta of 1.26.

上周五,APDN股价下跌0.82美元,至3.70美元。该股成交量为4,027,208股,而平均成交量为20,774,652股。该公司的50日移动均线价格为1.53美元,200日移动均线价格为1.89美元。应用DNA科学公司的股价跌至0.62美元的52周低点和7.35美元的52周高点。该公司市值为4433万美元,市盈率为-2.33,贝塔系数为1.26。

Get
到达
Applied DNA Sciences
应用DNA科学
alerts:
警报:

Analyst Upgrades and Downgrades

分析师升级和下调评级

Separately, HC Wainwright lowered their price target on Applied DNA Sciences from $6.00 to $4.00 and set a "na" rating for the company in a research report on Monday, May 16th.

另外,在5月16日周一的一份研究报告中,HC Wainwright将其对应用DNA科学的目标价从6.00美元下调至4.00美元,并将该公司的评级定为“NA”。

Institutional Trading of Applied DNA Sciences

应用DNA科学的制度性交易

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Virtu Financial LLC purchased a new position in shares of Applied DNA Sciences during the 1st quarter valued at about $49,000. State Street Corp raised its stake in shares of Applied DNA Sciences by 53.6% during the 1st quarter. State Street Corp now owns 26,977 shares of the technology company's stock valued at $58,000 after buying an additional 9,416 shares during the last quarter. Atria Wealth Solutions Inc. purchased a new position in shares of Applied DNA Sciences during the 1st quarter valued at about $67,000. Finally, Dimensional Fund Advisors LP raised its stake in shares of Applied DNA Sciences by 53.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 65,916 shares of the technology company's stock valued at $141,000 after buying an additional 22,843 shares during the last quarter. Institutional investors and hedge funds own 8.24% of the company's stock.
机构投资者和对冲基金最近增持或减持了该公司的股份。Virtu Financial LLC在第一季度购买了应用DNA科学公司的新头寸,价值约49,000美元。道富集团在第一季度增持了应用DNA科学公司的股份53.6%。道富集团目前持有26,977股这家科技公司的股票,价值58,000美元,此前在上个季度又购买了9,416股。Atria Wealth Solutions Inc.在第一季度购买了一股新的应用DNA科学公司股票,价值约6.7万美元。最后,Dimension Fund Advisors LP在第一季度将其在应用DNA Science的股份增加了53.0%。Dimension Fund Advisors LP现在拥有这家科技公司65,916股股票,价值141,000美元,上个季度又购买了22,843股。机构投资者和对冲基金持有该公司8.24%的股份。

Applied DNA Sciences Company Profile

应用DNA科学公司简介

(Get Rating)

(获取评级)

Applied DNA Sciences, Inc develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims.

应用DNA科学公司开发和销售基于DNA的技术解决方案,用于基于核酸的体外诊断和基于临床前核酸的药物开发和制造市场;以及用于供应链安全、防伪和防盗技术目的。该公司的供应链安全和产品认证解决方案包括签名分子标签,它为用于加强品牌保护努力和加强供应链安全的各种应用提供法医力量和保护,以及标记、跟踪和定罪罪犯;标志便携式DNA读取器和消耗品试剂检测试剂盒,提供现场分子标签的实时身份验证;以及确定性,表明使用了标签、测试和跟踪平台和解决方案,使制造商、品牌和贸易组织能够传达其产品声明的证据。

Read More

阅读更多内容

  • Get a free copy of the StockNews.com research report on Applied DNA Sciences (APDN)
  • MarketBeat: Week in Review 8/8 – 8/12
  • 2 Important Retail Stock Battles to Watch
  • What Is WallStreetBets and What Stocks Are They Targeting?
  • Institutions And Analysts Propel Jack In The Box Higher
  • Can You Guess Which EV Stock Is Beating Tesla ?
  • 免费获取StockNews.com关于应用DNA科学的研究报告(APDN)
  • MarketBeat:回顾中的一周2012-8-8
  • 值得关注的两场重要的零售股大战
  • 什么是WallStreetBets,他们的目标是什么股票?
  • 机构和分析师推动Jack in the Box走高
  • 你能猜到哪个电动车股票打败了特斯拉吗?

Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

获得《应用DNA科学日报》的新闻和评级-在下面输入您的电子邮件地址,以通过MarketBeat.com的免费每日电子邮件时事通讯接收对应用DNA科学和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发